QA06

ICD-11 MMS 2026-01

Follow-up examination after treatment for malignant neoplasms

Index terms

  • Follow-up examination after treatment for malignant neoplasms
  • examination following treatment for malignant neoplasm
  • medical surveillance following treatment for malignant neoplasms
Show allHide
  • Follow-up examination after surgery for malignant neoplasm
  • medical surveillance following surgical treatment for malignant neoplasm
  • Follow-up examination after radiotherapy for malignant neoplasm
  • medical surveillance following radiotherapy treatment for malignant neoplasm
  • Follow-up examination after chemotherapy for malignant neoplasm
  • medical surveillance following chemotherapy for malignant neoplasm
  • Follow-up examination after combined treatment for malignant neoplasm
  • medical surveillance following combined treatment for malignant neoplasm

Inclusions

  • medical surveillance following treatment for malignant neoplasms

Excludes

  • http://id.who.int/icd/entity/1144088229 – follow-up medical care and convalescence
  • QB85 – Attention to surgical dressings, drains or sutures

Exclusions from above levels

  • http://id.who.int/icd/entity/1144140024 – examinations related to pregnancy and reproduction
  • http://id.who.int/icd/entity/1617090159 – Clinical findings in blood, blood-forming organs, or the immune system

Sibling codes

  • QA00 – General examination or investigation of persons without complaint or reported diagnosis
  • QA01 – Examination or encounter for administrative purposes
  • QA02 – Medical observation or evaluation for suspected diseases or conditions, ruled out
  • QA03 – Routine general health check-up of defined subpopulation
  • QA04 – Examination or observation for reasons other than suspected diseases or conditions or administrative purposes
  • QA05 – Person consulting for explanation of investigation findings
  • QA07 – Follow-up examination after treatment for conditions other than malignant neoplasms
  • QA08 – Special screening examination for infectious diseases
  • QA09 – Special screening examination for neoplasms
  • QA0A – Special screening examination for other diseases or disorders
  • QA0B – Preprocedural examination
  • QA0Y – Other examination or investigation
  • QA0Z – Examination or investigation, unspecified

Foundation entity

Follow-up examination after treatment for malignant neoplasms – http://id.who.int/icd/entity/1638642396

Part of: 24: Factors influencing health status or contact with health services